UniProt ID | ANXA2_HUMAN | |
---|---|---|
UniProt AC | P07355 | |
Protein Name | Annexin A2 | |
Gene Name | ANXA2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 339 | |
Subcellular Localization | Secreted, extracellular space, extracellular matrix, basement membrane . Melanosome . In the lamina beneath the plasma membrane. Identified by mass spectrometry in melanosome fractions from stage I to stage IV. Translocated from the cytoplasm to the | |
Protein Description | Calcium-regulated membrane-binding protein whose affinity for calcium is greatly enhanced by anionic phospholipids. It binds two calcium ions with high affinity. May be involved in heat-stress response. Inhibits PCSK9-enhanced LDLR degradation, probably reduces PCSK9 protein levels via a translational mechanism but also competes with LDLR for binding with PCSK9. [PubMed: 18799458] | |
Protein Sequence | MSTVHEILCKLSLEGDHSTPPSAYGSVKAYTNFDAERDALNIETAIKTKGVDEVTIVNILTNRSNAQRQDIAFAYQRRTKKELASALKSALSGHLETVILGLLKTPAQYDASELKASMKGLGTDEDSLIEIICSRTNQELQEINRVYKEMYKTDLEKDIISDTSGDFRKLMVALAKGRRAEDGSVIDYELIDQDARDLYDAGVKRKGTDVPKWISIMTERSVPHLQKVFDRYKSYSPYDMLESIRKEVKGDLENAFLNLVQCIQNKPLYFADRLYDSMKGKGTRDKVLIRIMVSRSEVDMLKIRSEFKRKYGKSLYYYIQQDTKGDYQKALLYLCGGDD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSTVHEILC ------CCCHHHHHH | 38.85 | - | |
2 | O-linked_Glycosylation | ------MSTVHEILC ------CCCHHHHHH | 38.85 | 23301498 | |
2 | Phosphorylation | ------MSTVHEILC ------CCCHHHHHH | 38.85 | 23401153 | |
3 | Phosphorylation | -----MSTVHEILCK -----CCCHHHHHHH | 25.28 | 30266825 | |
9 | Glutathionylation | STVHEILCKLSLEGD CCHHHHHHHHHCCCC | 5.24 | 22833525 | |
9 | S-palmitoylation | STVHEILCKLSLEGD CCHHHHHHHHHCCCC | 5.24 | 29575903 | |
10 | Acetylation | TVHEILCKLSLEGDH CHHHHHHHHHCCCCC | 37.35 | 23954790 | |
10 | Ubiquitination | TVHEILCKLSLEGDH CHHHHHHHHHCCCCC | 37.35 | - | |
12 | Phosphorylation | HEILCKLSLEGDHST HHHHHHHHCCCCCCC | 15.18 | 29255136 | |
16 | Phosphorylation | CKLSLEGDHSTPPSA HHHHCCCCCCCCCHH | 24.16 | 24719451 | |
18 | Phosphorylation | LSLEGDHSTPPSAYG HHCCCCCCCCCHHHC | 47.55 | 29255136 | |
19 | O-linked_Glycosylation | SLEGDHSTPPSAYGS HCCCCCCCCCHHHCC | 35.48 | OGP | |
19 | Phosphorylation | SLEGDHSTPPSAYGS HCCCCCCCCCHHHCC | 35.48 | 29255136 | |
20 | Phosphorylation | LEGDHSTPPSAYGSV CCCCCCCCCHHHCCE | 24.70 | - | |
20 (in isoform 2) | Phosphorylation | - | 24.70 | 8898866 | |
21 | Phosphorylation | EGDHSTPPSAYGSVK CCCCCCCCHHHCCEE | 31.51 | - | |
21 (in isoform 2) | Phosphorylation | - | 31.51 | 17081983 | |
22 | Phosphorylation | GDHSTPPSAYGSVKA CCCCCCCHHHCCEEE | 35.01 | 29255136 | |
24 | Phosphorylation | HSTPPSAYGSVKAYT CCCCCHHHCCEEEEC | 17.80 | 29255136 | |
26 | Phosphorylation | TPPSAYGSVKAYTNF CCCHHHCCEEEECCC | 14.04 | 29255136 | |
28 | Acetylation | PSAYGSVKAYTNFDA CHHHCCEEEECCCCH | 37.06 | 26051181 | |
28 | Ubiquitination | PSAYGSVKAYTNFDA CHHHCCEEEECCCCH | 37.06 | 21906983 | |
28 (in isoform 2) | Ubiquitination | - | 37.06 | - | |
30 | Nitration | AYGSVKAYTNFDAER HHCCEEEECCCCHHH | 9.12 | - | |
30 | Phosphorylation | AYGSVKAYTNFDAER HHCCEEEECCCCHHH | 9.12 | 21945579 | |
30 (in isoform 2) | Phosphorylation | - | 9.12 | 29743597 | |
31 | Phosphorylation | YGSVKAYTNFDAERD HCCEEEECCCCHHHH | 33.98 | 21945579 | |
36 | Phosphorylation | AYTNFDAERDALNIE EECCCCHHHHCCCHH | 53.60 | 27642862 | |
37 | Phosphorylation | YTNFDAERDALNIET ECCCCHHHHCCCHHH | 35.90 | 27642862 | |
40 | Phosphorylation | FDAERDALNIETAIK CCHHHHCCCHHHHHH | 8.54 | 27642862 | |
42 | Phosphorylation | AERDALNIETAIKTK HHHHCCCHHHHHHCC | 5.31 | 27642862 | |
44 | Phosphorylation | RDALNIETAIKTKGV HHCCCHHHHHHCCCC | 29.86 | 21815630 | |
46 (in isoform 2) | Ubiquitination | - | 8.32 | - | |
47 | Acetylation | LNIETAIKTKGVDEV CCHHHHHHCCCCCEE | 41.54 | 23236377 | |
47 | Ubiquitination | LNIETAIKTKGVDEV CCHHHHHHCCCCCEE | 41.54 | 21906983 | |
48 | Phosphorylation | NIETAIKTKGVDEVT CHHHHHHCCCCCEEE | 27.24 | 21609022 | |
49 | Acetylation | IETAIKTKGVDEVTI HHHHHHCCCCCEEEE | 52.51 | 21466224 | |
49 | Phosphorylation | IETAIKTKGVDEVTI HHHHHHCCCCCEEEE | 52.51 | 27251275 | |
49 | Sumoylation | IETAIKTKGVDEVTI HHHHHHCCCCCEEEE | 52.51 | 25114211 | |
49 | Ubiquitination | IETAIKTKGVDEVTI HHHHHHCCCCCEEEE | 52.51 | 21906983 | |
55 | Phosphorylation | TKGVDEVTIVNILTN CCCCCEEEEEEEECC | 19.70 | 20068231 | |
61 | Phosphorylation | VTIVNILTNRSNAQR EEEEEEECCCCCHHH | 25.45 | 63753367 | |
65 (in isoform 2) | Ubiquitination | - | 36.53 | - | |
67 (in isoform 2) | Ubiquitination | - | 48.06 | - | |
75 | Phosphorylation | RQDIAFAYQRRTKKE HHHHHHHHHHHCHHH | 8.97 | 28152594 | |
79 | Phosphorylation | AFAYQRRTKKELASA HHHHHHHCHHHHHHH | 48.97 | 27251275 | |
80 | Malonylation | FAYQRRTKKELASAL HHHHHHCHHHHHHHH | 42.30 | 26320211 | |
81 | Malonylation | AYQRRTKKELASALK HHHHHCHHHHHHHHH | 58.30 | 26320211 | |
81 | Ubiquitination | AYQRRTKKELASALK HHHHHCHHHHHHHHH | 58.30 | - | |
85 | Phosphorylation | RTKKELASALKSALS HCHHHHHHHHHHHHC | 46.92 | 30266825 | |
88 | Ubiquitination | KELASALKSALSGHL HHHHHHHHHHHCCCH | 33.14 | - | |
89 | Phosphorylation | ELASALKSALSGHLE HHHHHHHHHHCCCHH | 34.98 | 34801879 | |
92 | Phosphorylation | SALKSALSGHLETVI HHHHHHHCCCHHHHH | 24.71 | 28450419 | |
93 | Phosphorylation | ALKSALSGHLETVIL HHHHHHCCCHHHHHH | 30.19 | - | |
97 | Phosphorylation | ALSGHLETVILGLLK HHCCCHHHHHHHHHC | 21.14 | 28450419 | |
99 (in isoform 2) | Ubiquitination | - | 3.09 | - | |
103 | Phosphorylation | ETVILGLLKTPAQYD HHHHHHHHCCHHHCC | 5.72 | 27251275 | |
104 | Acetylation | TVILGLLKTPAQYDA HHHHHHHCCHHHCCH | 58.46 | 23954790 | |
104 | Ubiquitination | TVILGLLKTPAQYDA HHHHHHHCCHHHCCH | 58.46 | 21906983 | |
105 | Phosphorylation | VILGLLKTPAQYDAS HHHHHHCCHHHCCHH | 24.67 | 21815630 | |
109 | Phosphorylation | LLKTPAQYDASELKA HHCCHHHCCHHHHHH | 18.64 | 23927012 | |
110 | Phosphorylation | LKTPAQYDASELKAS HCCHHHCCHHHHHHH | 31.38 | 27251275 | |
112 | Phosphorylation | TPAQYDASELKASMK CHHHCCHHHHHHHHC | 40.33 | 22199227 | |
115 | Acetylation | QYDASELKASMKGLG HCCHHHHHHHHCCCC | 34.07 | 23954790 | |
115 | Ubiquitination | QYDASELKASMKGLG HCCHHHHHHHHCCCC | 34.07 | 21906983 | |
117 | Phosphorylation | DASELKASMKGLGTD CHHHHHHHHCCCCCC | 21.31 | 23927012 | |
118 | Sulfoxidation | ASELKASMKGLGTDE HHHHHHHHCCCCCCH | 4.82 | 28183972 | |
119 | Acetylation | SELKASMKGLGTDED HHHHHHHCCCCCCHH | 48.79 | 26051181 | |
119 | Malonylation | SELKASMKGLGTDED HHHHHHHCCCCCCHH | 48.79 | 26320211 | |
119 | Succinylation | SELKASMKGLGTDED HHHHHHHCCCCCCHH | 48.79 | 23954790 | |
119 | Ubiquitination | SELKASMKGLGTDED HHHHHHHCCCCCCHH | 48.79 | - | |
122 | Acetylation | KASMKGLGTDEDSLI HHHHCCCCCCHHHHH | 39.53 | 19608861 | |
122 | Ubiquitination | KASMKGLGTDEDSLI HHHHCCCCCCHHHHH | 39.53 | 19608861 | |
122 (in isoform 2) | Ubiquitination | - | 39.53 | - | |
123 | Phosphorylation | ASMKGLGTDEDSLIE HHHCCCCCCHHHHHH | 41.06 | 23927012 | |
127 | Phosphorylation | GLGTDEDSLIEIICS CCCCCHHHHHHHHHH | 29.24 | 20201521 | |
130 | Phosphorylation | TDEDSLIEIICSRTN CCHHHHHHHHHHCCH | 31.43 | 27251275 | |
133 | S-nitrosocysteine | DSLIEIICSRTNQEL HHHHHHHHHCCHHHH | 2.50 | - | |
133 | Acetylation | DSLIEIICSRTNQEL HHHHHHHHHCCHHHH | 2.50 | 19608861 | |
133 | Glutathionylation | DSLIEIICSRTNQEL HHHHHHHHHCCHHHH | 2.50 | 22833525 | |
133 | S-nitrosylation | DSLIEIICSRTNQEL HHHHHHHHHCCHHHH | 2.50 | 22178444 | |
133 | S-palmitoylation | DSLIEIICSRTNQEL HHHHHHHHHCCHHHH | 2.50 | 29575903 | |
133 (in isoform 2) | Ubiquitination | - | 2.50 | - | |
134 | Phosphorylation | SLIEIICSRTNQELQ HHHHHHHHCCHHHHH | 31.56 | 46164657 | |
136 | Phosphorylation | IEIICSRTNQELQEI HHHHHHCCHHHHHHH | 25.59 | 20873877 | |
137 (in isoform 2) | Ubiquitination | - | 32.02 | - | |
141 | Phosphorylation | SRTNQELQEINRVYK HCCHHHHHHHHHHHH | 49.09 | - | |
145 | Phosphorylation | QELQEINRVYKEMYK HHHHHHHHHHHHHHC | 38.51 | 27251275 | |
147 | Phosphorylation | LQEINRVYKEMYKTD HHHHHHHHHHHHCCH | 9.67 | 20068231 | |
148 | Acetylation | QEINRVYKEMYKTDL HHHHHHHHHHHCCHH | 32.90 | 25825284 | |
148 | Malonylation | QEINRVYKEMYKTDL HHHHHHHHHHHCCHH | 32.90 | 26320211 | |
148 | Ubiquitination | QEINRVYKEMYKTDL HHHHHHHHHHHCCHH | 32.90 | 19608861 | |
148 (in isoform 1) | Ubiquitination | - | 32.90 | 21890473 | |
151 | S-nitrosocysteine | NRVYKEMYKTDLEKD HHHHHHHHCCHHHHH | 16.30 | - | |
151 | Phosphorylation | NRVYKEMYKTDLEKD HHHHHHHHCCHHHHH | 16.30 | 30622161 | |
152 | Acetylation | RVYKEMYKTDLEKDI HHHHHHHCCHHHHHH | 33.96 | 25825284 | |
152 | Malonylation | RVYKEMYKTDLEKDI HHHHHHHCCHHHHHH | 33.96 | 26320211 | |
152 | Ubiquitination | RVYKEMYKTDLEKDI HHHHHHHCCHHHHHH | 33.96 | 19608861 | |
153 | O-linked_Glycosylation | VYKEMYKTDLEKDII HHHHHHCCHHHHHHH | 28.47 | 23301498 | |
153 | Phosphorylation | VYKEMYKTDLEKDII HHHHHHCCHHHHHHH | 28.47 | 20068231 | |
157 | Acetylation | MYKTDLEKDIISDTS HHCCHHHHHHHCCCC | 62.62 | 23954790 | |
157 | Ubiquitination | MYKTDLEKDIISDTS HHCCHHHHHHHCCCC | 62.62 | 21906983 | |
161 | Phosphorylation | DLEKDIISDTSGDFR HHHHHHHCCCCHHHH | 34.86 | 30266825 | |
163 | Phosphorylation | EKDIISDTSGDFRKL HHHHHCCCCHHHHHH | 28.02 | 30266825 | |
164 | Phosphorylation | KDIISDTSGDFRKLM HHHHCCCCHHHHHHH | 41.16 | 30266825 | |
165 | Phosphorylation | DIISDTSGDFRKLMV HHHCCCCHHHHHHHH | 39.92 | - | |
166 | Acetylation | IISDTSGDFRKLMVA HHCCCCHHHHHHHHH | 39.69 | 19608861 | |
166 | Ubiquitination | IISDTSGDFRKLMVA HHCCCCHHHHHHHHH | 39.69 | 21890473 | |
166 (in isoform 2) | Ubiquitination | - | 39.69 | 21890473 | |
169 | Malonylation | DTSGDFRKLMVALAK CCCHHHHHHHHHHHC | 40.71 | 26320211 | |
169 | Methylation | DTSGDFRKLMVALAK CCCHHHHHHHHHHHC | 40.71 | - | |
169 | Ubiquitination | DTSGDFRKLMVALAK CCCHHHHHHHHHHHC | 40.71 | - | |
170 | Acetylation | TSGDFRKLMVALAKG CCHHHHHHHHHHHCC | 2.66 | 19608861 | |
170 | Ubiquitination | TSGDFRKLMVALAKG CCHHHHHHHHHHHCC | 2.66 | 19608861 | |
170 (in isoform 2) | Ubiquitination | - | 2.66 | - | |
171 | Phosphorylation | SGDFRKLMVALAKGR CHHHHHHHHHHHCCC | 1.53 | - | |
171 | Sulfoxidation | SGDFRKLMVALAKGR CHHHHHHHHHHHCCC | 1.53 | 30846556 | |
175 | Acetylation | RKLMVALAKGRRAED HHHHHHHHCCCCCCC | 11.52 | 19608861 | |
175 | Ubiquitination | RKLMVALAKGRRAED HHHHHHHHCCCCCCC | 11.52 | 19608861 | |
175 (in isoform 2) | Ubiquitination | - | 11.52 | - | |
176 | Acetylation | KLMVALAKGRRAEDG HHHHHHHCCCCCCCC | 54.52 | 23236377 | |
176 | Malonylation | KLMVALAKGRRAEDG HHHHHHHCCCCCCCC | 54.52 | 26320211 | |
176 | Succinylation | KLMVALAKGRRAEDG HHHHHHHCCCCCCCC | 54.52 | 23954790 | |
176 | Ubiquitination | KLMVALAKGRRAEDG HHHHHHHCCCCCCCC | 54.52 | - | |
179 | Phosphorylation | VALAKGRRAEDGSVI HHHHCCCCCCCCCCC | 51.50 | 27251275 | |
182 | Phosphorylation | AKGRRAEDGSVIDYE HCCCCCCCCCCCCCE | 54.40 | 27251275 | |
184 | Phosphorylation | GRRAEDGSVIDYELI CCCCCCCCCCCCEEC | 28.37 | 30266825 | |
187 (in isoform 2) | Ubiquitination | - | 28.79 | - | |
188 | Phosphorylation | EDGSVIDYELIDQDA CCCCCCCCEECCCCH | 11.08 | 23927012 | |
194 (in isoform 2) | Ubiquitination | - | 39.56 | - | |
199 | Phosphorylation | DQDARDLYDAGVKRK CCCHHHHHHHCCCCC | 14.18 | 27273156 | |
202 | Phosphorylation | ARDLYDAGVKRKGTD HHHHHHHCCCCCCCC | 23.68 | 27251275 | |
204 | Acetylation | DLYDAGVKRKGTDVP HHHHHCCCCCCCCCC | 47.69 | 26051181 | |
204 | Ubiquitination | DLYDAGVKRKGTDVP HHHHHCCCCCCCCCC | 47.69 | 21906983 | |
206 | Phosphorylation | YDAGVKRKGTDVPKW HHHCCCCCCCCCCHH | 61.52 | 27642862 | |
212 | Acetylation | RKGTDVPKWISIMTE CCCCCCCHHHHHHCC | 57.94 | 23954790 | |
212 | Ubiquitination | RKGTDVPKWISIMTE CCCCCCCHHHHHHCC | 57.94 | 21906983 | |
215 | Phosphorylation | TDVPKWISIMTERSV CCCCHHHHHHCCCCC | 12.75 | 9403753 | |
217 | Phosphorylation | VPKWISIMTERSVPH CCHHHHHHCCCCCHH | 2.25 | - | |
217 | Sulfoxidation | VPKWISIMTERSVPH CCHHHHHHCCCCCHH | 2.25 | 30846556 | |
218 | Phosphorylation | PKWISIMTERSVPHL CHHHHHHCCCCCHHH | 26.95 | 82570423 | |
221 | Phosphorylation | ISIMTERSVPHLQKV HHHHCCCCCHHHHHH | 33.49 | 30266825 | |
222 (in isoform 2) | Ubiquitination | - | 4.30 | - | |
227 | Acetylation | RSVPHLQKVFDRYKS CCCHHHHHHHHHHHC | 51.75 | 23954790 | |
227 | Methylation | RSVPHLQKVFDRYKS CCCHHHHHHHHHHHC | 51.75 | 19608861 | |
227 | Succinylation | RSVPHLQKVFDRYKS CCCHHHHHHHHHHHC | 51.75 | 23954790 | |
227 | Ubiquitination | RSVPHLQKVFDRYKS CCCHHHHHHHHHHHC | 51.75 | 19608861 | |
227 (in isoform 1) | Ubiquitination | - | 51.75 | 21890473 | |
230 (in isoform 2) | Ubiquitination | - | 56.86 | - | |
232 | Phosphorylation | LQKVFDRYKSYSPYD HHHHHHHHHCCCHHH | 13.21 | 23312004 | |
233 | Acetylation | QKVFDRYKSYSPYDM HHHHHHHHCCCHHHH | 43.76 | 25825284 | |
233 | Malonylation | QKVFDRYKSYSPYDM HHHHHHHHCCCHHHH | 43.76 | 26320211 | |
233 | Phosphorylation | QKVFDRYKSYSPYDM HHHHHHHHCCCHHHH | 43.76 | 27251275 | |
233 | Ubiquitination | QKVFDRYKSYSPYDM HHHHHHHHCCCHHHH | 43.76 | - | |
234 | Phosphorylation | KVFDRYKSYSPYDML HHHHHHHCCCHHHHH | 23.16 | 21945579 | |
235 | Phosphorylation | VFDRYKSYSPYDMLE HHHHHHCCCHHHHHH | 14.98 | 21945579 | |
236 | Phosphorylation | FDRYKSYSPYDMLES HHHHHCCCHHHHHHH | 24.87 | 21945579 | |
238 | Nitration | RYKSYSPYDMLESIR HHHCCCHHHHHHHHH | 14.19 | - | |
238 | Phosphorylation | RYKSYSPYDMLESIR HHHCCCHHHHHHHHH | 14.19 | 21945579 | |
239 | Phosphorylation | YKSYSPYDMLESIRK HHCCCHHHHHHHHHH | 38.28 | 27251275 | |
240 | Sulfoxidation | KSYSPYDMLESIRKE HCCCHHHHHHHHHHH | 3.54 | 30846556 | |
243 | Phosphorylation | SPYDMLESIRKEVKG CHHHHHHHHHHHHCC | 24.59 | 21945579 | |
245 | Acetylation | YDMLESIRKEVKGDL HHHHHHHHHHHCCHH | 38.06 | 19608861 | |
245 | Ubiquitination | YDMLESIRKEVKGDL HHHHHHHHHHHCCHH | 38.06 | 21890473 | |
245 (in isoform 2) | Ubiquitination | - | 38.06 | 21890473 | |
246 | Ubiquitination | DMLESIRKEVKGDLE HHHHHHHHHHCCHHH | 66.25 | - | |
249 | Ubiquitination | ESIRKEVKGDLENAF HHHHHHHCCHHHHHH | 48.04 | - | |
251 (in isoform 2) | Ubiquitination | - | 45.12 | - | |
252 | Phosphorylation | RKEVKGDLENAFLNL HHHHCCHHHHHHHHH | 8.13 | 27251275 | |
253 | Phosphorylation | KEVKGDLENAFLNLV HHHCCHHHHHHHHHH | 51.78 | 17389395 | |
256 | Phosphorylation | KGDLENAFLNLVQCI CCHHHHHHHHHHHHH | 7.58 | 27642862 | |
262 | Glutathionylation | AFLNLVQCIQNKPLY HHHHHHHHHHCCCCH | 2.42 | 14668336 | |
262 | S-nitrosylation | AFLNLVQCIQNKPLY HHHHHHHHHHCCCCH | 2.42 | 25040305 | |
266 | Acetylation | LVQCIQNKPLYFADR HHHHHHCCCCHHHHH | 21.74 | 21466224 | |
266 | Sumoylation | LVQCIQNKPLYFADR HHHHHHCCCCHHHHH | 21.74 | - | |
266 | Ubiquitination | LVQCIQNKPLYFADR HHHHHHCCCCHHHHH | 21.74 | 21906983 | |
269 | Phosphorylation | CIQNKPLYFADRLYD HHHCCCCHHHHHHHH | 12.78 | 310709061 | |
275 | Phosphorylation | LYFADRLYDSMKGKG CHHHHHHHHHHCCCC | 13.58 | 19534553 | |
277 | Phosphorylation | FADRLYDSMKGKGTR HHHHHHHHHCCCCCC | 14.61 | 23312004 | |
279 | Acetylation | DRLYDSMKGKGTRDK HHHHHHHCCCCCCCH | 62.51 | 19608861 | |
279 | Malonylation | DRLYDSMKGKGTRDK HHHHHHHCCCCCCCH | 62.51 | 26320211 | |
279 | Ubiquitination | DRLYDSMKGKGTRDK HHHHHHHCCCCCCCH | 62.51 | 19608861 | |
281 | Ubiquitination | LYDSMKGKGTRDKVL HHHHHCCCCCCCHHH | 52.14 | - | |
296 | Phosphorylation | IRIMVSRSEVDMLKI EEEEECHHHHCHHHH | 34.17 | 21712546 | |
297 | Acetylation | RIMVSRSEVDMLKIR EEEECHHHHCHHHHH | 41.23 | 19608861 | |
297 (in isoform 2) | Ubiquitination | - | 41.23 | - | |
299 (in isoform 2) | Ubiquitination | - | 32.42 | - | |
302 | Acetylation | RSEVDMLKIRSEFKR HHHHCHHHHHHHHHH | 29.45 | 23954790 | |
302 | Ubiquitination | RSEVDMLKIRSEFKR HHHHCHHHHHHHHHH | 29.45 | 21906983 | |
305 | Phosphorylation | VDMLKIRSEFKRKYG HCHHHHHHHHHHHHC | 51.35 | 23312004 | |
310 | Acetylation | IRSEFKRKYGKSLYY HHHHHHHHHCCCCEE | 59.97 | 25825284 | |
310 | Malonylation | IRSEFKRKYGKSLYY HHHHHHHHHCCCCEE | 59.97 | 26320211 | |
313 | Acetylation | EFKRKYGKSLYYYIQ HHHHHHCCCCEEEEE | 33.91 | 23954790 | |
313 | Malonylation | EFKRKYGKSLYYYIQ HHHHHHCCCCEEEEE | 33.91 | 26320211 | |
313 | Methylation | EFKRKYGKSLYYYIQ HHHHHHCCCCEEEEE | 33.91 | 19608861 | |
313 | Ubiquitination | EFKRKYGKSLYYYIQ HHHHHHCCCCEEEEE | 33.91 | 19608861 | |
313 (in isoform 1) | Ubiquitination | - | 33.91 | 21890473 | |
314 | Phosphorylation | FKRKYGKSLYYYIQQ HHHHHCCCCEEEEEC | 19.76 | 30804295 | |
316 | Phosphorylation | RKYGKSLYYYIQQDT HHHCCCCEEEEECCC | 11.00 | 21082442 | |
317 | Phosphorylation | KYGKSLYYYIQQDTK HHCCCCEEEEECCCC | 10.21 | 27273156 | |
318 | Phosphorylation | YGKSLYYYIQQDTKG HCCCCEEEEECCCCC | 4.43 | 21082442 | |
320 | Acetylation | KSLYYYIQQDTKGDY CCCEEEEECCCCCCH | 20.98 | 19608861 | |
320 | Ubiquitination | KSLYYYIQQDTKGDY CCCEEEEECCCCCCH | 20.98 | 19608861 | |
320 (in isoform 2) | Ubiquitination | - | 20.98 | - | |
323 | Phosphorylation | YYYIQQDTKGDYQKA EEEEECCCCCCHHHH | 32.37 | 28152594 | |
324 | Acetylation | YYIQQDTKGDYQKAL EEEECCCCCCHHHHH | 59.06 | 23954790 | |
324 | Sumoylation | YYIQQDTKGDYQKAL EEEECCCCCCHHHHH | 59.06 | - | |
324 | Ubiquitination | YYIQQDTKGDYQKAL EEEECCCCCCHHHHH | 59.06 | 2190698 | |
327 | Phosphorylation | QQDTKGDYQKALLYL ECCCCCCHHHHHHHH | 22.15 | 28152594 | |
329 | Acetylation | DTKGDYQKALLYLCG CCCCCHHHHHHHHCC | 34.47 | 26051181 | |
329 | Ubiquitination | DTKGDYQKALLYLCG CCCCCHHHHHHHHCC | 34.47 | - | |
331 | Acetylation | KGDYQKALLYLCGGD CCCHHHHHHHHCCCC | 4.10 | 19608861 | |
331 | Ubiquitination | KGDYQKALLYLCGGD CCCHHHHHHHHCCCC | 4.10 | 21890473 | |
331 (in isoform 2) | Ubiquitination | - | 4.10 | 21890473 | |
332 | Phosphorylation | GDYQKALLYLCGGDD CCHHHHHHHHCCCCC | 3.52 | 27251275 | |
333 | Phosphorylation | DYQKALLYLCGGDD- CHHHHHHHHCCCCC- | 10.78 | 28152594 | |
334 | Phosphorylation | YQKALLYLCGGDD-- HHHHHHHHCCCCC-- | 1.90 | 27642862 | |
335 | Glutathionylation | QKALLYLCGGDD--- HHHHHHHCCCCC--- | 3.46 | 14668336 | |
335 | Phosphorylation | QKALLYLCGGDD--- HHHHHHHCCCCC--- | 3.46 | 27642862 | |
335 | S-palmitoylation | QKALLYLCGGDD--- HHHHHHHCCCCC--- | 3.46 | 29575903 | |
336 | Phosphorylation | KALLYLCGGDD---- HHHHHHCCCCC---- | 39.71 | 27642862 | |
342 (in isoform 2) | Ubiquitination | - | - | ||
347 (in isoform 2) | Ubiquitination | - | - | ||
351 | Phosphorylation | ------------------- ------------------- | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
12 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
24 | Y | Phosphorylation | Kinase | IGF1R | P08069 | PSP |
24 | Y | Phosphorylation | Kinase | SRC | P12931 | Uniprot |
24 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
26 | S | Phosphorylation | Kinase | PKCA | P04409 | PSP |
26 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
26 | S | Phosphorylation | Kinase | PKCA | P05696 | PSP |
26 | S | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
26 | S | Phosphorylation | Kinase | PKC-FAMILY | - | GPS |
26 | S | Phosphorylation | Kinase | PKC | - | Uniprot |
26 | S | Phosphorylation | Kinase | PKC_GROUP | - | PhosphoELM |
- | K | Ubiquitination | E3 ubiquitin ligase | CBLL1 | Q75N03 | PMID:31952268 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ANXA2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ANXA2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CATB_HUMAN | CTSB | physical | 10777578 | |
TPA_HUMAN | PLAT | physical | 12468550 | |
APOH_HUMAN | APOH | physical | 10809787 | |
S10AA_HUMAN | S100A10 | physical | 18434302 | |
STAT6_HUMAN | STAT6 | physical | 20121258 | |
GAG_HV1H2 | gag | physical | 16501079 | |
A4_HUMAN | APP | physical | 21832049 | |
RACK1_HUMAN | GNB2L1 | physical | 22939629 | |
RS13_HUMAN | RPS13 | physical | 22939629 | |
RL11_HUMAN | RPL11 | physical | 22939629 | |
MLH1_HUMAN | MLH1 | physical | 20706999 | |
HMGA1_HUMAN | HMGA1 | physical | 18850631 | |
DNJC8_HUMAN | DNAJC8 | physical | 22863883 | |
PA24A_HUMAN | PLA2G4A | physical | 14599294 | |
S10AA_HUMAN | S100A10 | physical | 26186194 | |
ANX13_HUMAN | ANXA13 | physical | 26186194 | |
EWS_HUMAN | EWSR1 | physical | 26344197 | |
PCBP2_HUMAN | PCBP2 | physical | 26344197 | |
PDCD6_HUMAN | PDCD6 | physical | 26344197 | |
PA24A_HUMAN | PLA2G4A | physical | 18065419 | |
S10AA_HUMAN | S100A10 | physical | 18065419 | |
S10AA_HUMAN | S100A10 | physical | 28514442 | |
ANX13_HUMAN | ANXA13 | physical | 28514442 | |
AHNK2_HUMAN | AHNAK2 | physical | 28514442 | |
KLH42_HUMAN | KLHL42 | physical | 28514442 | |
STAT3_HUMAN | STAT3 | physical | 23691485 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00031 | Tenecteplase |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-104; LYS-115; LYS-148;LYS-152; LYS-157; LYS-227; LYS-279; LYS-302 AND LYS-313, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY. | |
"The protein-tyrosine kinase substrate p36 is also a substrate forprotein kinase C in vitro and in vivo."; Gould K.L., Woodgett J.R., Isacke C.M., Hunter T.; Mol. Cell. Biol. 6:2738-2744(1986). Cited for: PHOSPHORYLATION AT SER-26. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-275, AND MASSSPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-24; TYR-30; TYR-188 ANDTYR-238, AND MASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-24, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-24; TYR-30; TYR-188;TYR-199; TYR-238; TYR-316; TYR-317 AND TYR-318, AND MASS SPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-30, AND MASSSPECTROMETRY. | |
"An annexin 2 phosphorylation switch mediates p11-dependenttranslocation of annexin 2 to the cell surface."; Deora A.B., Kreitzer G., Jacovina A.T., Hajjar K.A.; J. Biol. Chem. 279:43411-43418(2004). Cited for: PHOSPHORYLATION AT TYR-24, AND MUTAGENESIS OF TYR-24. |